- Home
- FLS vs RVMD Comparison
FLS vs RVMD Comparison
Compare FLS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- RVMD
- Stock Information
- Founded
- FLS 1790
- RVMD 2014
- Country
- FLS United States
- RVMD United States
- Employees
- FLS N/A
- RVMD N/A
- Industry
- FLS Fluid Controls
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLS Industrials
- RVMD Health Care
- Exchange
- FLS Nasdaq
- RVMD Nasdaq
- Market Cap
- FLS 8.3B
- RVMD 7.4B
- IPO Year
- FLS N/A
- RVMD 2020
- Fundamental
- Price
- FLS $53.29
- RVMD $37.22
- Analyst Decision
- FLS Strong Buy
- RVMD Strong Buy
- Analyst Count
- FLS 9
- RVMD 12
- Target Price
- FLS $64.11
- RVMD $68.67
- AVG Volume (30 Days)
- FLS 3.4M
- RVMD 3.1M
- Earning Date
- FLS 07-28-2025
- RVMD 08-06-2025
- Dividend Yield
- FLS 1.81%
- RVMD N/A
- EPS Growth
- FLS 20.22
- RVMD N/A
- EPS
- FLS 2.14
- RVMD N/A
- Revenue
- FLS $4,614,870,000.00
- RVMD N/A
- Revenue This Year
- FLS $7.11
- RVMD N/A
- Revenue Next Year
- FLS $3.67
- RVMD $241.39
- P/E Ratio
- FLS $21.70
- RVMD N/A
- Revenue Growth
- FLS 4.23
- RVMD N/A
- 52 Week Low
- FLS $37.34
- RVMD $29.17
- 52 Week High
- FLS $65.08
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- FLS 64.87
- RVMD 39.42
- Support Level
- FLS $45.11
- RVMD $37.00
- Resistance Level
- FLS $47.63
- RVMD $40.70
- Average True Range (ATR)
- FLS 1.30
- RVMD 1.65
- MACD
- FLS 0.28
- RVMD -0.33
- Stochastic Oscillator
- FLS 97.82
- RVMD 9.06
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.